Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07330778 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of CDX-622 in Participants With Mild to Moderate Asthma

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Jun 2026 to Jun 1, 2026
    • Eligibility criteria expanded, about 14 words
    v8
  2. Site contacts updated at 4 of 4 sitesv7
  3. Start date: Feb 2026 to Jun 2026
    • Study sites: 2 to 4
    v6
  4. Study sites: 1 to 2v5
  5. Start date: Jan 2026 to Feb 2026v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.
Trial Details
NCT Number NCT07330778
Lead Sponsor Celldex Therapeutics
Conditions
(from sponsor)		 Mild to Moderate Asthma
Related terms Asthma
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov